Eargo

Eargo tackled hearing aid stigma, a genuine barrier preventing millions of younger seniors aged 55-70 from treating hearing loss. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌This demographic's avoidance was measurable: adoption rates remained stubbornly low despite rising prevalence of age-related decline. Traditional competitors like Phonak and ReSound dominated through established audiology networks and insurance partnerships, while Eargo's invisible, direct-to-consumer model promised to bypass these gatekeepers. However, the company overlooked critical warning signs. Hearing loss requires professional fitting and ongoing adjustments—services that audiologists provided but Eargo's remote model couldn't replicate effectively. Customer acquisition costs soared as marketing to seniors proved expensive. More fundamentally, Eargo misread its market: many seniors actually valued professional guidance and didn't view stigma as their primary barrier. Insurance reimbursement remained elusive without audiologist involvement. The company's financial struggles and eventual bankruptcy revealed that solving stigma alone wasn't enough when the underlying distribution model couldn't support the clinical complexity hearing aid users actually needed.